Long Term Clinical Outcomes of Paclitaxel Drug Eluting Stent in Diabetic Population

Antimitotic agents like a microtubular stabilizing agent would be better in diabetics to prevent the reverse activation of protein kinase B. Whether paclitaxel on a thinner strut eliminate the differences in the long term clinical outcomes in diabetics was studied.

Bibliographische Detailangaben

Veröffentlicht in:	The American journal of cardiology 2013-04, Vol.111 (7), p.31B-31B
Hauptverfasser:	Tummala, Karthik, Maniyal, Vijay Kumar, Chandrashekar, Rajiv, Kumaraswamy, Natarajan, Kamath, Prakash
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular Clinical outcomes Kinases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!